Fe 3 O 4 @Au core-shell hybrid nanocomposite for MRI-guided magnetic targeted photo-chemotherapy

The combination of multiple therapeutic and diagnostic functions is fast becoming a key feature in the area of clinical oncology. The advent of nanotechnology promises multifunctional nanoplatforms with the potential to deliver multiple therapeutics while providing diagnostic information simultaneou...

Full description

Saved in:
Bibliographic Details
Published inLasers in medical science
Main Authors Khani, Tahereh, Alamzadeh, Zahra, Sarikhani, Abolfazl, Mousavi, Mahdie, Mirrahimi, Mehri, Tabei, Mousa, Irajirad, Rasoul, Abed, Ziaeddin, Beik, Jaber
Format Journal Article
LanguageEnglish
Published England 23.01.2022
Subjects
Photothermal therapy
Chemotherapy
Fe3O4@Au core–shell nanoparticles
Magnetic resonance imaging
Magnetic drug targeting
Online AccessGet full text

Cover

More Information
Summary:The combination of multiple therapeutic and diagnostic functions is fast becoming a key feature in the area of clinical oncology. The advent of nanotechnology promises multifunctional nanoplatforms with the potential to deliver multiple therapeutics while providing diagnostic information simultaneously. In this study, novel iron oxide-gold core-shell hybrid nanocomposites (Fe O @Au HNCs) coated with alginate hydrogel carrying doxorubicin (DOX) were constructed for targeted photo-chemotherapy and magnetic resonance imaging (MRI). The magnetic core enables the HNCs to be detected through MRI and targeted towards the tumor using an external magnetic field, a method known as magnetic drug targeting (MDT). The Au shell could respond to light in the near-infrared (NIR) region, generating a localized heating for photothermal therapy (PTT) of the tumor. The cytotoxicity assay showed that the treatment of CT26 colon cancer cells with the DOX-loaded HNCs followed by laser irradiation induced a significantly higher cell death as opposed to PTT and chemotherapy alone. The in vivo MRI study proved MDT to be an effective strategy for targeting the HNCs to the tumor, thereby enhancing their intratumoral concentration. The antitumor study revealed that the HNCs can successfully combine chemotherapy and PTT, resulting in superior therapeutic outcome. Moreover, the use of MDT following the injection of HNCs caused a more extensive tumor shrinkage as compared to non-targeted group. Therefore, the as-prepared HNCs could be a promising nanoplatform for image-guided targeted combination therapy of cancer.
ISSN:1435-604X